Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1026 | 1061 | 1062 | 1118 | 1395 | 1943 |
Fund Return | 2.58% | 6.14% | 6.24% | 3.78% | 6.89% | 6.87% |
Place in category | 222 | 124 | 112 | 297 | 94 | 31 |
% in Category | 32 | 19 | 19 | 54 | 22 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquZD | 1.53B | 6.20 | 3.22 | 7.69 | ||
Pictet CH Institutional Swiss EquiI | 1.53B | 6.08 | 2.73 | 7.19 | ||
Pictet CH Institutional Swiss EquiP | 1.53B | 6.02 | 2.53 | 6.98 | ||
Pictet CH Institutional Swiss EquPD | 1.53B | 2.54 | 3.57 | 6.65 | ||
Pictet CH Institutional Swiss EquiZ | 1.53B | 2.66 | 4.28 | 7.37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.35B | 6.76 | 5.03 | 6.69 | ||
Raiffeisen Futura Swiss Stock A | 2.07B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.01B | 2.59 | 4.20 | 6.41 | ||
UBS CH Equity Fund Swiss Income CHF | 2.01B | 2.43 | 3.56 | 5.81 | ||
UBAM Swiss Equity AD CHF Inc | 1.72B | 7.99 | -0.55 | 5.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 15.83 | 92.70 | +0.67% | |
Roche Holding Participation | CH0012032048 | 11.15 | 221.00 | +1.01% | |
Novartis | CH0012005267 | 10.16 | 89.50 | -0.56% | |
Zurich Insurance Group | CH0011075394 | 5.31 | 439.90 | -0.61% | |
ABB | CH0012221716 | 5.30 | 44.94 | +0.97% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Strong Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review